Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Core Scientific's EBITDA for the
three
months ended in Jun. 2026 was €2.6 Mil. Core Scientific's Revenue for the
three
months ended in Jun. 2026 was €142.5 Mil. Therefore, Core Scientific's EBITDA margin for the quarter that ended in Jun. 2026 was 1.81%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Core Scientific EBITDA Margin % Related Terms
Core Scientific EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Core Scientific's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1CORZ vs DBX, MBGL, S: EBITDA Margin % Comparison
For the Software - Infrastructure subindustry, Core Scientific's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Scientific EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Core Scientific's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Core Scientific's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Scientific (MIL:1CORZ) has a EBITDA Margin % of 1.81% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Core Scientific and its competitors. According to the industry distribution chart, Core Scientific ranks #2544 out of 2826 companies in the Software industry, placing it in the top 90%.
Is Core Scientific's EBITDA Margin % too high?
Core Scientific's current EBITDA Margin % is 1.81%. The Software industry median EBITDA Margin % is 8.15. Core Scientific's value of 1.81% is 77.8% below this industry median. Based on the distribution chart, Core Scientific ranks #2544 out of 2826 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Core Scientific has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Core Scientific's EBITDA Margin % compare to DBX and MBGL?
According to the Software industry distribution chart, Core Scientific ranks #2544 out of 2826 companies for EBITDA Margin %. This places Core Scientific in the lower half of its industry. The industry median EBITDA Margin % is 8.15. Core Scientific's value of 1.81% is 77.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.15, based on 2,826 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Scientific's current EBITDA Margin % of 1.81% is 77.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Core Scientific and its competitors. For the Software industry, the median EBITDA Margin % is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Scientific's current EBITDA Margin % is 1.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Scientific stock overvalued right now?
Based on GuruFocus' analysis, Core Scientific (MIL:1CORZ) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.18, compared to a current price of €18.76 — trading 104.3% above its estimated fair value. The current EBITDA Margin % is 1.81% and 77.8% below the Software industry median of 8.15. Core Scientific's overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Core Scientific (MIL:1CORZ), the current EBITDA Margin % is 1.81% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Scientific (MIL:1CORZ) Overvalued in 2026?
Based on GuruFocus' analysis, Core Scientific stock appears to be overvalued.
The current stock price of €18.76 is trading 104.3% above its estimated GF Value™ of €9.18.
GuruFocus considers Core Scientific to be Significantly Overvalued.
Key valuation signals for MIL:1CORZ:
EBITDA Margin %: 1.81%
GF Value™: €9.18 vs. price of €18.76 (104.3% above fair value)
Industry Position: 77.8% below the Software median (#2544 of 2826)
No single metric tells the full story. See the MIL:1CORZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Scientific Inc is engaged in designing, building, and operating digital infrastructure for high-density colocation services and digital asset mining. The business operates in three operating segments: Digital Asset Self-Mining, consisting of performing digital asset mining for its own account, Digital Asset Hosted Mining, consisting of providing hosting services to third parties for digital asset mining, and Colocation, consisting of providing high-density colocation services to third parties for AI / HPC operations. The majority of revenue is derived from the Digital Asset Self-Mining Segment.
36GF Score
Get the complete analysis for MIL:1CORZ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CORZ has been successfully added to your 
